Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
Why Earnings Season Could Be Great for Arcturus Therapeutics (ARCT)?
02:35pm, Friday, 07'th Aug 2020
Arcturus Therapeutics (ARCT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Arcturus Therapeutics Appoints Lance Kurata as Chief Legal Officer
12:30pm, Thursday, 06'th Aug 2020
Nationally recognized leader in corporate life sciences transactionsSAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT),
With Biotech Stocks, Investors Love the Thrill of the Chase
09:30am, Wednesday, 05'th Aug 2020
Individual investors are placing their bets on biotech companies pursuing coronavirus advances. Some invest for fun and profit, while others want to be a part of a historic breakthrough.
Novavax Reported Promising Data on Covid-19 Vaccine. Its Stock Fell Anyway.
09:23pm, Tuesday, 04'th Aug 2020
Novovax shares have climbed nearly 4,000% so far this year on excitement over the company’s Covid-19 vaccine.
Phase 3 Trials And More: Any COVID-19 Data Is Good Data, Even If It's Bad
07:59pm, Tuesday, 04'th Aug 2020
MRNA, PFE/BNTX, and AZN are leading the three vaccines in clinical phase 3 trials. Vaccines developed using different vectors have different advantages and disadvantages.
7 Growth Stocks to Ride for the Rest of 2020
07:20pm, Tuesday, 04'th Aug 2020
Investors can count on these growth stocks to deliver consistent, positive returns for the remainder of this year and beyond.
Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020
12:30pm, Tuesday, 04'th Aug 2020
SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on
Bull Signal Flashing for Moderna Stock Ahead of Earnings - Schaeffer's Investment Research
06:59am, Tuesday, 04'th Aug 2020
Moderna (MRNA) stock just pulled back to a long-term bullish trendline on the charts , and has cheap options to boot
-$0.36 Earnings Per Share Expected for Moderna Inc (NASDAQ:MRNA) This Quarter
06:48am, Tuesday, 04'th Aug 2020
Wall Street analysts forecast that Moderna Inc (NASDAQ:MRNA) will report earnings per share (EPS) of ($0.36) for the current quarter, Zacks Investment Research reports. Five analysts have issued estim
Novavax Says Coronavirus Vaccine Generated 'Robust Antibody Responses' In Phase 1 Trial Participants
12:00am, Tuesday, 04'th Aug 2020
Novavax, Inc (NASDAQ: VAX) announced Tuesday its novel coronavirus (COVID-19) vaccine elicited "robust antibody responses" in participants of the Phase 1...
Stocks Climb to Start the Month as New Virus Cases Fall
05:16pm, Monday, 03'rd Aug 2020
The Nasdaq Composite is once again leading the major indexes higher. Investors are hoping more news later this week around unemployment could help extend the gains.
MorphoSys FDA Approval, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:MOR)
04:12pm, Monday, 03'rd Aug 2020
MorphoSys receives FDA approval for Monjuvi. Brigham president tenders resignation from Moderna board after conflict of interest.
We Could Know if Moderna’s Covid-19 Vaccine Works by Halloween, Analyst Says
03:03pm, Monday, 03'rd Aug 2020
Jefferies analyst estimates the biotech’s Phase 3 trial has a 65% chance of working.
And The COVID-19 Vaccine Winner Is: 'BioNTech SE' (NASDAQ:BNTX)
06:30am, Monday, 03'rd Aug 2020
The BioNTech/Pfizer team has launched its Phase 2/3 clinical trial in the USA and internationally for its COVID-19 vaccine on July 27, 2020, after excellent Phase 1/2 clinical trial results.
Indigo Ag Announces an Additional $360M in Financing, Appoints Stéphane Bancel, Moderna CEO, to Board of Directors
12:00am, Monday, 03'rd Aug 2020
Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces the closing of $360M in additional
